课题基金 / 基金详情

IDENTIFICATION OF PATIENTS WITH FAMILIAL PHEOCHROMOCYTOMA/VON HIPPLE LINDAU SYN

IDENTIFICATION OF PATIENTS WITH FAMILIAL PHEOCHROMOCYTOMA/VON HIPPLE LINDAU SYN
家族性嗜铬细胞瘤/VON HIPPLE LINDAU SYN 患者的识别
批准号:
6114599
负责人:
SALLY CARTY
金额:
$2.9万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:

项目摘要

项目成果

SALLY CARTY的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Prospective investigation of families with an apparent excess of pheochromocytoma will allow earlier detection, syndrome delineation and improved outcome. Pheochromocytoma is a neoplasm of the adrenal medulla that is usually benign, sporadic and unilateral, and such cases are not the subject of this protocol. Pheochromocytoma is occasionally one manifestation of inherited autosomal dominant endocrine/neurologic disorders. These include, but are not limited to MEN-IIa, MEN-IIb, von Hippel-Lindau disease )VHL), and neurofibromatosis.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
IDENTIFICATION OF PATIENTS W/ FAMILIAL HYPOCALCIURIC HYPERCALCEMIA
IDENTIFICATION OF PATIENTS WITH MULTIPLE ENDOCRINE NEOPLASIA TYPE I
IDENTIFICATION OF PATIENTS W/ FAMILIAL HYPOCALCIURIC HYPERCALCEMIA
IDENTIFICATION OF PATIENTS WITH MULTIPLE ENDOCRINE NEOPLASIA TYPE I
海外基金